Skip to content

Clinical trials

Lymphoma, B-Cell trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Country / region: Switzerland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20051
20063
20071
20091
20101
20161
20193
20213
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Terminated2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
International Extranodal Lymphoma Study Group (IELSG)2
Novartis Pharmaceuticals2
Pfizer2
Swiss Cancer Institute2
Debiopharm International SA1
Hoffmann-La Roche1
Lymphoma Study Association1
Merck KGaA, Darmstadt, Germany1
Sandoz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell19
Lymphoma, Non-Hodgkin8
Lymphoma6
Hematologic Diseases3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Recurrence3
Dendritic Cell Sarcoma, Interdigitating2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Follicular2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.